Shinpoong Pharmaceutical Co Ltd (019175) — Capital Reinvestment Ratio

Latest as of March 2026: 0.09x

Shinpoong Pharmaceutical Co Ltd (019175) has a Capital Reinvestment Ratio of 0.09x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩6.36 Billion) in capital expenditures (₩557.84 Million). Check Shinpoong Pharmaceutical Co Ltd (019175) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.09x
Capex / Operating Cash Flow

Operating Cash Flow

₩6.36 Billion
KRW

Capital Expenditures

₩557.84 Million
KRW

Data as of

Mar 2026
Most recent filing

Shinpoong Pharmaceutical Co Ltd Capital Reinvestment Ratio (2015–2025)

This chart tracks Shinpoong Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see Shinpoong Pharmaceutical Co Ltd cash flow conversion.

Annual Capital Reinvestment Ratio for Shinpoong Pharmaceutical Co Ltd (2015–2025)

Year-by-year Capital Reinvestment Ratio for Shinpoong Pharmaceutical Co Ltd from 2015 to 2025. See Shinpoong Pharmaceutical Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2025 0.23x ₩17.25 Billion ₩3.99 Billion ▲ +74.8%
2020 0.13x ₩20.06 Billion ₩2.65 Billion ▼ -78.8%
2019 0.62x ₩19.35 Billion ₩12.07 Billion ▲ +1015.9%
2018 0.06x ₩32.05 Billion ₩1.79 Billion ▼ -81.6%
2017 0.30x ₩10.15 Billion ₩3.08 Billion ▲ +283.0%
2016 0.08x ₩18.96 Billion ₩1.50 Billion ▼ -58.7%
2015 0.19x ₩9.89 Billion ₩1.90 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow